Žarko Mitić

Žarko Mitić

Auto-generated profile, based on publicly available information

Žarko Mitić

Department of Chemistry, Faculty of Medicine, University of Nis, 18000 Niš, Serbia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
ŽMŽarko Mitić
Žarko Mitić
ASAleksandra Stolić
Aleksandra Stolić
Sanja StojanovićSanja Stojanović
Sanja Stojanović
Stevo J. NajmanStevo J. Najman
Stevo J. Najman
Nenad L. IgnjatovićNenad L. Ignjatović
Nenad L. Ignjatović
MTMiroslav Trajanović
Miroslav Trajanović

26 January 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SISnezana Ilic-Stojanovic
Snezana Ilic-Stojanovic
LNLjubisa Nikolic
Ljubisa Nikolic
VNVesna Nikolić
Vesna Nikolić
SPSlobodan Dragoslav Petrović
Slobodan Dragoslav Petrović
VOVioleta Oro
Violeta Oro
Stevo J. NajmanStevo J. Najman
Stevo J. Najman
In this study, poly(N-isopropylacrylamide-co-2-hydroxypropyl methacrylate) hydrogels were synthesized using free radical initiated copolymerization method. Four hydrogels with different cross-linker concentrations were prepared. Semi-crystalline, cross-linked copolymer networks were confirmed by FTIR, SEM and XRD analysis. Variation of swelling behaviour was monitored gravimetrically and thermo-responsiveness has been noticed. An application of synthesized thermo-responsive hydrogels as carriers for the modulated release of anti-inflammatory model drug was investigated. Moreover, naproxen loading into these hydrogels was also determined using FTIR, SEM and XRD techniques and release was analyzed using HPLC method at simulated physiological conditions. Swelling kinetic and mechanism of water transport, as well as diffusion of naproxen through the hydrogels were analyzed. Thus, the aim of this work was to study various compositions of obtained hydrogels and their possibility of application as a thermo-responsive carrier for prolonged naproxen release in order to evaluate as a potential candidate for drug carrier in future pharmaceutical applications.

1 November 2018 in Carbohydrate Polymers
Verified
Journal Article
Closed access
ŽMŽarko Mitić
Žarko Mitić
Goran NikolicGoran Nikolic
Goran Nikolic
MCMilorad Cakić
Milorad Cakić
GNGoran S. Nikolić
Goran S. Nikolić
SŽSlavoljub Živanović
Slavoljub Živanović
Stevo J. NajmanStevo J. Najman
Stevo J. Najman

1 January 2007 in Hemijska industrija
Verified
Journal Article
Open access
ZMZarko Mitic
Zarko Mitic
Goran NikolicGoran Nikolic
Goran Nikolic
MCMilorad Cakic
Milorad Cakic
RNRuzica Nikolic
Ruzica Nikolic
LILjubomir Ilic
Ljubomir Ilic
Co(II) ion complex compounds were synthesized with reduced dextran (RD) in alkali solutions using CoCl2, 6H2O and isolated in the solid state. UV-VIS spectrophotometric investigations of Co(II) complexes with reduced dextran showed that the complexation of Co(II) ions begins at pH over 7. The formation of Co(II) ion complexes with dextran monomer units was observed at pH 7-13. With increase in solution pH the light absorption maximum of complex solutions shifts to longer wavelengths (bat-hochromic shift) compared with [Co(H2O)6]2+ ion. Dextran complexes with Co(II) ion are formed by the displacement of water molecules from the coordination sphere of cobalt by the OH ligand groups. The spectrophotometric parameters of the investigated complexes are characteristic of a Co(II) ion in octahedral or distorted octahedral coordination with O ligand atoms.

15 December 2011 in Acta Medica Medianae
Verified
Journal Article
Closed access
MVMarija Vukelić
Marija Vukelić
ŽMŽarko Mitić
Žarko Mitić
MMMiroslav Miljković
Miroslav Miljković
JŽJelena Živković
Jelena Živković
Nenad L. IgnjatovićNenad L. Ignjatović
Nenad L. Ignjatović
Stevo J. NajmanStevo J. Najman
Stevo J. Najman

10 March 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AVAleksandar M Veselinović
Aleksandar M Veselinović
GCGiulia Culletta
Giulia Culletta
JŽJelena Vladeta Živković
Jelena Vladeta Živković
SSSlavica Sunarić
Slavica Sunarić
ŽMŽarko Mitić
Žarko Mitić
Marco TutoneMarco Tutone
Marco Tutone
Background/Objectives: Serotonin transporter (SERT) inhibition represents a central pharmacological strategy in the treatment of major depressive disorder. In this study, an integrated computational framework combining quantitative structure–activity relationship (QSAR) modeling, molecular docking analysis, and in silico ADMET profiling was applied to identify and prioritize novel candidate structures. Methods: Conformation-independent QSAR models were developed using local molecular graph invariants and SMILES-based descriptors optimized through a Monte Carlo learning procedure, while a genetic algorithm–multiple linear regression (GA–MLR) was employed to derive statistically robust predictive models from a large descriptor pool. Model quality, robustness, and external predictivity were rigorously evaluated using multiple statistical validation criteria. In parallel, a field-based contribution analysis was applied to construct a three-dimensional QSAR model, enabling spatial interpretation of structure–activity relationships. Fragment-level contributions associated with activity enhancement or attenuation were subsequently identified and used to design new candidate inhibitor structures. Results: The designed compounds were further evaluated by molecular docking, InducedFit Docking and Binding Pose MetaDynamics (BPMD) into the SERT binding site, providing a structure-based assessment consistent with the trends observed in QSAR modeling. In addition, in silico ADMET analysis was performed to assess key pharmacokinetic and safety-related properties relevant to central nervous system drug development. Conclusions: The proposed workflow demonstrates the utility of combining data-driven QSAR modeling with structure-based and pharmacokinetic considerations to rationalize and prioritize novel serotonin transporter-focused scaffold optimization, offering a transferable strategy for early-stage antidepressant drug discovery.